Who
Matthew Lingenbrink
Director
Company insider
Files Form 4 as: Director, FitLife Brands.
In numbers
- Trades disclosed
- 4
- Buys
- 3
- Sells
- 0
- Bought
- $129K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 31 Mar 2025
- Last trade
- 10 Apr 2026
- Last filed
- 14 Apr 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Apr 2026filed 14 Apr 2026 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Bought | $29K3,000 at $9.76 | filing |
| 10 Apr 2026filed 14 Apr 2026 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Bought | $29K3,000 at $9.76 | filing |
| 14 Apr 2025filed 16 Apr 2025 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Bought | $37K3,000 at $12.17 | filing |
| 31 Mar 2025filed 2 Apr 2025 | FTLF FitLife BrandsPharmaceuticals | SEC FORM 4 Bought | $34K2,800 at $12.17 | filing |
News
No headline names them, or the companies they trade most, lately.